Skip to content

The Role of Sound in Enhancing or Disabling the Placebo Effect of a Deactivated Transcutaneous Electrical Nerve Stimulator (TENS) Device on Hypoalgesia in Healthy Volunteers

The Role of Sound in Enhancing or Disabling the Placebo Effect of a Deactivated Transcutaneous Electrical Nerve Stimulator (TENS) Device on Hypoalgesia in Healthy Volunteers

Status
Completed
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06981260
Enrollment
38
Registered
2025-05-20
Start date
2016-06-13
Completion date
2016-06-14
Last updated
2025-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

Placebo responses are now recognized for their clinical and physiological significance. Non-pharmacological cues such as sound may enhance or induce these responses. This trial aims to assess the effect of sound on the placebo-induced hypoalgesia elicited by a deactivated TENS device in healthy individuals.

Interventions

PROCEDUREGroup A Deactivated TENS with beeping sound (15-second interval)

Deactivated TENS with beeping sound (15-second interval)

PROCEDUREGroup B

Deactivated TENS without sound

Sponsors

Aegean College, Athens, Greece
CollaboratorUNKNOWN
Coventry University, United Kingdom
CollaboratorUNKNOWN
Institute of Health and Resilience
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

Participant and assessor blinded

Intervention model description

A healthy volunteer pilot study.

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* No history of TENS use

Exclusion criteria

* Current medication use * Orthopedic, neurological, or systemic conditions * Pregnancy (current and planned)

Design outcomes

Primary

MeasureTime frameDescription
Change in pain pressure threshold (PPT) at L2 (lumbar spine) from baseline to post-intervention.From Baseliine to 5 minutesChange in pain pressure threshold (PPT) at L2 (2nd lumbar vertebra) from baseline to post-intervention. Measured using pressure algometer (Wagner Force Dial FDK/FDN Series).

Secondary

MeasureTime frameDescription
Effect of gender on placebo responseFrom Baseliine to 5 minutesEffect of gender on placebo response (ANOVA analysis on post-treatment PPT)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026